No results for ‘’
Brooks Laboratories Ltd
₹49.51
(2.25%)
Mon, 25 May 2026, 02:20 pm
Health Technology
Pharmaceuticals: Major
24.5KBrooks Laboratories Share Price Live Chart
1 Day
(2.25%)
No Result Found
Summary
Market Cap
159.36
Net Profit
-9.97
P/B
3.24
Sector P/E
34.11
P/E
0
EV/EBITDA
0
Debt/Equity (Industry)
0.24
Interest Cover (Industry)
9.79
ROCE (Industry)
14.05
RONW (Industry)
13.18
ROE
0
ROCE
0
Debt/Equity
0.08
EPS (TTM)
7.33
Dividend Yield
0
Book Value
39.27
Interest Cover
-8.50
Analysis
all
- Debt is covered by short term assets, assets are 1.2x debt.
- Brooks Laboratories's cash and other short term assets cover its long term commitments.
- Brooks Laboratories's level of debt (29.4%) compared to net worth is satisfactory (less than 40%).
- The tenure for the Brooks Laboratories board of directors is about average.
- Rajesh's remuneration is lower than average for companies of similar size in India.
- Unable to calculate sustainability of dividends as Brooks Laboratories has not reported any payouts.
- Unable to evaluate Brooks Laboratories's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
- Unable to evaluate Brooks Laboratories's dividend against the top 25% market benchmark as the company has not reported any payouts.
- Brooks Laboratories's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
- Operating cash flow is negative therefore debt is not well covered.
Shareholding
| Shareholders | MAR 2026 | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 |
|---|---|---|---|---|---|
| Promoters | 52.62 | 52.62 | 52.62 | 52.62 | 52.62 |
| FII | 0.17 | 0.09 | 0.01 | 0 | 0.05 |
| DII | 10.38 | 10.38 | 10.38 | 10.38 | 10.38 |
| Public | 36.84 | 36.91 | 37.00 | 37.00 | 36.95 |
| Government | 0 | 0 | 0 | 0 | 0 |
Technical Analysis
Support and Resistance
| Type | R3 | R2 | R1 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 139.66 | 98.94 | 77.46 | 58.22 | 36.74 | 17.50 | - |
| Fibonacci | 98.94 | 83.38 | 73.78 | 58.22 | 42.66 | 33.06 | 17.50 |
| Camarilla | 67.18 | 63.45 | 59.71 | 58.22 | 52.25 | 48.51 | 44.78 |
Pivots Level: Classic
R3
+81.44
139.66
R2
+40.72
98.94
R1
+19.24
77.46
S1
-21.48
36.74
S2
-40.72
17.50
S3
-58.22
-
Moving Average
Period
Value
10-EMA
51.69
20-EMA
53.14
30-EMA
54.79
50-EMA
57.87
100-EMA
67.43
200-EMA
84.92
Corporate Actions
| Announcement Date | Purpose | Action | Ex Date |
|---|---|---|---|
| 06 Feb 2026 | board-meetings | Quarterly Results | |
| 14 Nov 2025 | board-meetings | Quarterly Results | |
| 08 Sept 2025 | agm | ||
| 19 Dec 2024 | egm | ||
| 02 Sept 2024 | agm | ||
| 12 Aug 2024 | agm | Annual General Meeting | 13 Sept 2024 |
| 30 Aug 2023 | agm | ||
| 14 Aug 2023 | agm | Annual General Meeting | 15 Sept 2023 |
| 18 Jul 2023 | rights | 1:16 Rights Issue of Equity Shares | 28 Jul 2023 |
| 28 Jun 2023 | rights | Right Issue of Equity Shares | 28 Jul 2023 |
Peer Comparison
Brooks Laboratories Ltd
Torrent Pharmaceuticals Ltd
Sun Pharmaceutical Industries Ltd
Cipla Ltd
Dr Reddys Laboratories Ltd
Divis Laboratories Ltd
Brooks Laboratories Ltd About
Brooks Laboratories is a pharmaceutical manufacturing company working on contract basis and have its own marketing team to cater the critical care segment.
Industry
Pharmaceuticals - Indian - Bulk Drugs & Formln
Founded
2002
Headquarters
CEO
Employees
Contact
Website
http://www.brookslabs.net
cs@brookslabs.net
Phone
91-1795-654001/02/03
Location
Village Kishanpura, Nilagarh Road Baddi, Solan, Himachal Pradesh, 174101
Brooks Laboratories Ltd Company History
| Year | History |
|---|---|
| 2013 |
|
| 2014 |
|
| 2015 |
|
| 2016 |
|
| 2023 |
|
Deals
| Client Name | Deal Type | Order Side | QTY | Avg Price | Date |
|---|---|---|---|---|---|
| RAMESH THAKURDAS JAISINGHANI | bulk | Sell | 170803 | 50.55 | 08 May 2026 |
| ATUL RANCHAL | bulk | Sell | 395011 | 136.4 | 14 Nov 2024 |
| ONE UP FINANCIAL CONSULTANTS PVT LTD | bulk | Buy | 400000 | 136.4 | 14 Nov 2024 |
| ARYAN MAHAJAN | bulk | Sell | 480000 | 137.4 | 14 Nov 2024 |
| ATUL RANCHAL | bulk | Sell | 200000 | 137.4 | 14 Nov 2024 |
| RR FAMILY TRUST | bulk | Buy | 218300 | 137.4 | 14 Nov 2024 |
| SARAVANA GLOBAL HOLDINGS LIMITED | bulk | Sell | 138398 | 92.12 | 16 May 2024 |
| MUKUL MAHESHWARI (HUF) | bulk | Buy | 131656 | 104.67 | 21 Apr 2022 |
| MUKUL MAHESHWARI (HUF) | bulk | Sell | 38423 | 104.83 | 21 Apr 2022 |
| GUTTIKONDA VARA LAKSHMI | bulk | Sell | 160000 | 89.25 | 03 Mar 2022 |